Provider Reminder When Billing Administration and Observation Codes for Spravato
As of January 1, 2021, a new code was created for Esketamine (S0013), which is sold under the brand name Spravato. Esketamine is a medication used as a general anesthetic for adults with treatment-resistant depression.
When Esketamine is supplied by a pharmacy using S0013, providers administering and observing the member receiving Esketamine should be filing with Evaluation and Management (E&M) and prolonged service codes as necessary.
When Esketamine is supplied by the provider or same practice who is also administering and observing the member, providers should be filing with G2082/G2083.
These changes apply to all commercial providers and to the following lines of business: Administrative Services Only (ASO groups), fully insured membership, and the State Health Plan (SHP).
Blue Cross and Blue Shield of North Carolina does not discriminate on the basis of race, color, national origin, sex, age or disability in its health programs and activities. Learn more about our non-discrimination policy and no-cost services available to you.
Information in other languages: Español 中文 Tiếng Việt 한국어 Français العَرَبِيَّة Hmoob ру́сский Tagalog ગુજરાતી ភាសាខ្មែរ Deutsch हिन्दी ລາວ 日本語
© 2024 Blue Cross and Blue Shield of North Carolina. ®, SM Marks of the Blue Cross and Blue Shield Association, an association of independent Blue Cross and Blue Shield plans. All other marks and names are property of their respective owners. Blue Cross and Blue Shield of North Carolina is an independent licensee of the Blue Cross and Blue Shield Association.